Selected Curriculum Vitae

Credentials

Licensure – Neurology American Board of Psychiatry/Neurology-Neurology and New York State Medical License

Title – Assistant Professor of Neurology, Northwell Health.

             Director of CMSC-recognized “Northwell MS Center”

Medical School – University of Pittsburgh School of Medicine

Residency – Mount Sinai Hospital and Medical Center

Internship – Mount Sinai Beth Israel — Petrie Division

Fellowship – Mount Sinai Hospital and Medical Center

Publications in the Field:

  1. Rempe-Thornton J, Harel A. Negative SARS-COV-2 antibody testing following COVID-19 infection in two MS patients treated with ocrelizumab. Mult Scler Relat Disord. 2020 Sep;44:102341.
  2. Valburg C, Sonti A, Stern JN, Najjar S, Harel A. Dietary factors in experimental autoimmune encephalomyelitis and multiple sclerosis: A comprehensive review. Mult Scler. 2020 May 14;1352458520923955.
  3. Fitzgerald D, Laurent M, Funaro M, Harel A, DeAngelis T, Bangeranye C, Najjar S, Tabansky I, Stern JNH. Defining the role of T lymphocytes in the immunopathogenesis of neuromyelitis optica spectrum disorder. Discov Med. Mar-Apr 2020;29(157):91-102.
  4. Raynowska J, Miskin DP, Pramanik B, Asiry S, Anderson T, Boockvar J, Najjar S, Harel A. Retinal Vasculopathy with Cerebral Leukoencephalopathy (RVCL): A Rare Mimic of Tumefactive MS. Neurology, Epub ahead of print.
  5. Sharp E, Colin M, Sayegh P, Blanter J, Steinklein J, Harel A. Central Nervous System Vasculitis Presenting as Hypertensive Crisis and Back Pain. Practical Neurology. Issue 9/2018, 90-95.
  6. Harel A, Horng S, Gustafson T, Ramineni A, Farber RS, Fabian M. Successful Treatment of Progressive Multifocal Leukoencephalopathy with Recombinant Interleukin-7 and Maraviroc in a Patient with Idiopathic CD4 Lymphocytopenia. J Neurovirol, Epub ahead of print.
  7. Harel A*, Sperling D*, Petracca M, Ntranos A, Katz-Sand I, Krieger S, Lublin F, Wang Z, Liu Y, Inglese M.  Brain Microstructural Injury Occurs in RRMS Patients Despite ‘No Evidence of Disease Activity’. JNNP, Epub ahead of print. * Authors contributed equally.
  8. Cocozza S, Petracca M, Mormina E, Buyukturkoglu K, Podranski K, Heinig M, Pontillo G, Russo C, Lanzillo R, Harel A, Klineova S, Miller A, Brunetti A, Brescia M, Lublin F, Inglese M.  Cerebellar Lobule Atrophy and Disability in Progressive MS. JNNP, Epub ahead of print.
  9. Pardini M, Petracca M, Harel A, Fleysher L, Oesingmann N, Bommarito G, Fabian M, Chard D, Lublin F, Inglese M.  The Relationship Between Cortical Lesions and Periventricular NAWM Abnormalities Suggests a Shared Mechanism of Injury in Primary-Progressive MS. NeuroImage: Clinical, 16:111-115, 2017.
  10. Harel A, Ceccarelli A, Farrell C, Fabian M, Howard J, Riley C, Miller A, Lublin F, Inglese M.  Phase-Sensitive Inversion-Recovery MRI Improves Longitudinal Cortical Lesion Detection in Progressive MS. PLoS One, 11(3): e0152180, 2016.
  11. Harel A, Katz-Sand I. Chapter 4: Treatment Strategies in Multiple Sclerosis, In: Handbook of Relapse-Remitting Multiple Sclerosis, 1st Edition, Aaron Miller (Ed.), Springer, 67-97, 2017.
  12. Straus Farber R*, Harel A*, Lublin F.  Novel Agents for Relapsing Forms of Multiple Sclerosis. Annual Review of Medicine, 67:309-21, 2016. * Authors contributed equally.

Presentations and Posters

  1. Harel A, Krieger S, Ayeni O, Brandstadter R, Inglese M, Lewis C, Miller A, Pelle G, Lublin F, Sumowski J.  Independent Contributions of Cervical Cord Lesions and Thalamic, Cerebellar, and Putaminal Volumes to Upper Extremity Function in Early MS.  7th Joint ECTRIMS-ACTRIMS Meeting, Paris, France, October 2017.
  2. Harel A.  An Update on Multiple Sclerosis: Investigating the Clinical-Radiological Paradox.  Department of Neurology Grand Rounds, Zucker School of Medicine at Hofstra/Northwell, New York, NY, October 2017.
  3. Sperling D, Harel A, Petracca M, Farrell C, Katz-Sand Il, Inglese M.  Microstructural Deterioration in Multiple Sclerosis Patients Meeting Criteria for “No Evidence of Disease Activity”: Correlations with Clinical Variables.  2017 American Academy of Neurology (AAN) Annual Meeting, Boston, MA, April 2017.
  4. Ayeni O, Krieger S, Brandstadter R, Harel A, Petracca M, Lewis C, Lublin F, Miller A, Pelle G, Pepe A, Inglese M, Sumowski J.  Improved Clinical Detection of Cerebellar Lesions in Multiple Sclerosis Patients. 2018 American Academy of Neurology (AAN) Annual Meeting, Los Angeles, California, April 2018.
  5. Sharp E, Harel A, Colin M, Sayegh P, Blantar J. The Importance of rapid diagnosis and treatment of CNS vasculitis presenting as hypertensive crisis and back pain. 2018 Society of General Internal Medicine Annual Meeting, Denver, Colorado, April 2018.
  6. Harel A, Sperling D, Petracca M, Ntranos A, Inglese M.  Myelin Deterioration Occurs in RRMS Patients Meeting Criteria for “No Evidence of Disease Activity”. 7th Joint ECTRIMS-ACTRIMS Meeting, Paris, France, October 2017.
  7. Petracca M, Cocozza S, Mormina E, Buyukturkoglu K, Podranski K, Heinig MM, Pontillo G, Russo C, Tedeschi E, Russo CV, Costabile T, Lanzillo R, Harel A, Klineova S, Miller A, Brunetti A, Brescia Morra V, Lublin F, Inglese M.  “Unicuique suum”: Cerebellar Lobule Atrophy and Distability in Multiple Sclerosis Phenotypes. 7th Joint ECTRIMS-ACTRIMS Meeting, Paris, France, October 2017.
  8. Ayeni O, Krieger S, Brandstadter R, Harel A, Inglese M, Lewis C, Lublin F, Miller A, Pelle G, Pepe A, Petracca M, Sumowski J.  Improved Clinical Detection of Cerebellar Dysfunction in Early MS. 7th Joint ECTRIMS-ACTRIMS Meeting, Paris, France, October 2017.
  9. Harel A, Saiote C, Farrell C, Sperling D, Katz-Sand I, Inglese M.  Longitudinal Evaluation of Diffusion Tensor Imaging Measures in Patients Meeting Criteria for “No Evidence of Disease Activity”.  2016 European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Annual Meeting, London, UK, September 2016.
  10. Harel A, Petracca M, Bencosme Y, Katz-Sand I, Lublin F, Inglese M, Ceccarelli A.  Contribution of Cortical Lesions to Cognitive Dysfunction in the PPMS Population: Comparison of Double Inversion Recovery (DIR) and Phase Sensitive Inversion Recovery (PSIR) Sequences Using a 3 Tesla MRI.  2015 American Academy of Neurology (AAN) Annual Meeting, Washington, DC, April 2015.

Press Mentions

Is ‘No Evidence of Disease Activity’ a Misnomer in MS?

Upper Extremity Composite Picks Up Early MS

MS Drug Poses Hard Choices for Women Wanting Children

Sunnier Days in Youth May Mean Less Odds of MS Later